Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Discovery of Potential Anti-Ischemic Stroke Agents Through Inhibiting Sulfonylurea Receptor 1 (Sur1): A Pharmacophore-Based Screening, Docking, and Molecular Dynamic Simulation Publisher



Boroomandnezhad M1 ; Amanlou A2 ; Zareei S1 ; Akhavan N3 ; Amanlou M1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Medical Nanotechnology, Faculty of Advanced Sciences and Technology, Medical Sciences Branch, Islamic Azad University (IAUMS), Tehran, Iran

Source: Biointerface Research in Applied Chemistry Published:2022


Abstract

Stroke is the leading cause of disability and death worldwide. Inhibition of sulfonylurea 1 receptor (SUR1) using glibenclamide previously has been studied in CNS ischemic tissues and faster recovery from stroke injury in different animal models of stroke. Unfortunately, glibenclamide cannot enter the brain through an intact brain membrane (BBB) due to its ionization at physiological pH. Therefore, it was hypothesized that compounds with structural properties similar to glibenclamide but with the ability to penetrate through BBB would be superior to glibenclamide in ischemic stroke. Docking energy and interactions of glibenclamide with SUR1 active site were assessed using AutoDock Vina. NCI databases search engines with limitations for penetration to CNS were used to find the best compounds with desired properties. Then two selected compounds were assessed with dynamic molecular studies. Two compounds called CID-415537 and CID-419074 with docking energies of-10.3 kcal/mol and-11 kcal/mol were identified. CID-415537 was selected as the best compound due to its proper interactions with SUR1 amino acids and stability in molecular dynamic simulation. Based on this study, compound CID-415537 would be a good candidate for a SUR1 inhibitor in ischemic stroke. However, further in vivo investigations are required to confirm these findings. © 2021 by the authors.
2. Structure-Based Virtual Screening for Defeating Drug Resistant Form of Egfr Protein, Combinatorial Chemistry and High Throughput Screening (2016)
Experts (# of related papers)
Other Related Docs
19. Drug Repurposing for Targeting Fibronectin in Treatment of Endometriosis and Cancers, Journal of Biomolecular Structure and Dynamics (2023)
23. Epigenetic-Based Cancer Therapeutics: New Potential Hdac8 Inhibitors, Journal of Biomolecular Structure and Dynamics (2022)
31. Therapeutic Effects of Anti-Diabetic Drugs on Traumatic Brain Injury, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2024)
32. Computational Design of Trkb Peptide Inhibitors and Their Biological Effects on Ovarian Cancer Cell Lines, International Journal of Peptide Research and Therapeutics (2016)